Estatísticas para RT 1533 2019 - ANTI-VEGF (Avastin®, Eyla® ou Lucentis®) para Edema Macular Diabético - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| RT 1533 2019 - ANTI-VEGF (Avastin®, Eyla® ou Lucentis®) para Edema Macular Diabético - NATJUS TJMG | 4 |
Total visitas por mês
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visitas Arquivos
| views | |
|---|---|
| RT 1533.pdf | 2 |